OGN News and Press, Organon & Co.

New analysis of pooled Phase 3 data will evaluate efficacy and safety of VTAMA cream across age groups in pediatric and adult patients with atopic dermatitis (AD) Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthi...

2026-06-25 13:59:34 ET More on Merck, Eli Lilly, etc. Is GSK Quietly Becoming An Oncology Powerhouse AbbVie Inc. (ABBV) Apogee Therapeutics, Inc. - M&A Call - Slideshow AbbVie Inc. (ABBV) M&A Call Transcript Eli Lilly's Foundayo, Zepbound available to...

Are TBRG, OGN, MDV Obtaining Fair Deals for their Shareholders? PR Newswire Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Share...

2026-06-23 06:28:40 ET More on Organon Organon & Co. (OGN) Shareholder/Analyst Call - Slideshow Organon: What The Buyout Rumors Mean For The Stock Organon Takeover At $15? Probably Not, Here's Why Insider trades: Intel, Bank of America, and Pinterest amon...

The launch expands Organon’s biosimilars portfolio in Canada to eight products spanning five therapeutic areas Organon Canada and Shanghai Henlius Biotech, Inc. (2696.HK) today announced that BILDYOS ® (denosumab injection) 60 mg/1 mL and TUZEMTY ® (denosumab ...

This transaction strengthens Organon’s contraception portfolio and expands long-acting reversible options for women Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced the comple...

The amended agreement deepens Organon and Samsung Bioepis’s collaboration to six biosimilars in Canada across multiple therapeutic areas, including immunology, oncology and dermatology. To be launched in Canada in 2026 Samsung Bioepis and Organon, a global healthcar...

Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) approval of the supplemental Biologics License Application (sBLA) for TOFIDENCE ® (tocilizumab-bavi) injection, for intravenous use, a biosimilar to ACTEMRA (tocilizumab). The approval expands TOFIDENCE indicat...

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - June 2, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Organon & Co. ("Organon" or the "Company") (NYSE - OGN) for possible breaches of fiduciary duty and other violat...

2026-05-18 07:39:18 ET More on iShares Core S&P Mid-Cap ETF, Vanguard Mid-Cap Index Fund ETF, etc. The 1-Minute Market Report, May 17, 2026 The 1-Minute Market Report, April 26, 2026 VOT Is Struggling In 2026, Consider Core Mid-Cap Growth ETFs Trump says ...